|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/498 | |
| A61P 27/02 |
| (11) | Number of the document | 1758552 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05741206.6 |
| Date of filing the European patent application | 2005-04-26 | |
| (97) | Date of publication of the European application | 2007-03-07 |
| (45) | Date of publication and mention of the grant of the patent | 2011-07-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/014607 |
| Date | 2005-04-26 |
| (87) | Number | WO 2005/110368 |
| Date | 2005-11-24 |
| (30) | Number | Date | Country code |
| 836911 | 2004-04-30 | US |
| (72) |
BURKE, James, US
HUGHES, Patrick, M., US
ZHANG, Kai-Ming, US
LIN, Ton, US
HUANG, Glenn, US
JACKSON, Brittany, A., US
WHEELER, Larry, A., US
DONN, Rosy, S., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | INTRAOCULAR IMPLANTS OF ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR PREVENTING OR REDUCING OCULAR VASCULAR OCCLUSIONS |
| INTRAOCULAR IMPLANTS OF ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR PREVENTING OR REDUCING OCULAR VASCULAR OCCLUSIONS |